VASCVERSA LTD

Company number NI657918 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

-£10,654

Balance sheet as at 2026-03-31

View full accounts →

What it does

The principal activity of the company continued to be that of

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2018-12-20
Employees
6 (2026 accounts · was 5 in 2025)
Registered office
63 University Road, Belfast, Antrim, Northern Ireland, BT7 1NF
Postcode
BT7 1NF
Capital
38 GBP
Accounts category
Micro

Accounts

Last made up to
2026-03-31
Next due by
2027-12-31
Financial year end
31 March

Confirmation statement

Last statement dated
2026-07-06
Next due by
2027-07-20
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 5 current

Appointed 2021-03-31
Appointed 2021-03-31
Appointed 2021-03-31
Appointed 2018-12-20
QUBIS LTD Corporate Director · corporate
Appointed 2018-12-20

View all officers and resignations →

Contact details

Website
vascversa.com

Vascversa is a Regenerative Medicine Company developing exciting new cell therapies that promote vascular regeneration and repair. Spun out of Queen's University Belfast and built on over 20 years of research.

At this address

3rd largest employer

of 21 similar companies in BT, with 6 staff.

Competitors Belfast

This company ranks 29 among research and experimental development on biotechnology in Belfast.

Full league table →

The class of 2018

36%

of the 439 companies in this sector incorporated in 2018 are still active today; 60% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →